Clinical Trial: Assessment of Total Pulmonary Resistance sPAP/CO Between Sea Level LA vs. High Altitude HA After Re-ascent in Patients With Pulmonary Arterial Hypertension PAH

U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07804693) titled 'Assessment of Total Pulmonary Resistance sPAP/CO Between Sea Level LA vs. High Altitude HA After Re-ascent in Patients With Pulmonary Arterial Hypertension PAH' on Aug. 17.

Brief Summary: To study the effect of a re-ascent after a one-week stay at sea level (after prior descent from 2850m) to high altitude (Quito Ecuador: 2850m) on pulmonary resistance (sPAP/CO) and other hemodynamic outcomes in patients with pulmonary arterial hypertension PAH, who live permanently >2600m.

Study Start Date: Sept. 25

Study Type: INTERVENTIONAL

Condition: Pulmonary Arterial Hypertension (PAH) Pulmonary Vascular Disease High Altitude Echocardiogra...